Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: Perspective of a surgical oncologist

Familial Cancer

Volumn 7, Issue 1, 2008, Pages 91-95

  Silva, Edibaldo ^a  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Clinical management; Genetic counseling; High risk breast cancer pedigree

Indexed keywords

TAMOXIFEN;

ALGORITHM; BREAST CANCER; CONFERENCE PAPER; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC RISK; GERM LINE; HIGH RISK POPULATION; HUMAN; MASTECTOMY; MEDICAL DECISION MAKING; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; ARTICLE; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; METHODOLOGY; MUTATION; PRIMARY HEALTH CARE; RISK;

ALGORITHMS; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MASTECTOMY; PRIMARY HEALTH CARE; RISK;

EID: 46449116833     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-007-9167-3     Document Type: Conference Paper

References (26)

1. A Stolier G Fuhrman 2004 Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA1 or BRCA2 mutation Breast J 10 475 480
2. A Ganguly K Leahy 1997 Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations Genet Test 2 85 90
3. SR Lakhani MJ van de Vijver 2002 The pathology of familial breast cancer: predictive value of immunohistochemical markers, estrogen receptor, progesterone receptor, HER-2 Neu and p53 in patients with mutations in BRCA1 and BRCA2 J Clin Oncol 20 2310 2318
4. WD Foulkes K Metcalfe 2003 Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma Cancer 98 1569 1577
5. CTM Brekelmans C Seynaeve 2001 Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk J Clin Oncol 19 924 930
6. L Scheuer N Kauf 2002 Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers J Clin Oncol 20 1260 1268
7. G Schwartz GN Hortogyi 2004 Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of breast, April 26-28, 2003, Philadelphia, Pennsylvania Cancer 100 2512 2532
8. N Wolmark J Wang E Mamounas 2001 Preoperative chemotherapy in patients with operable breast cancer: nine-year results from NSABP B-18 J Natl Cancer Inst Monogr 30 96 102
9. B Cady M Chung 2006 Re: genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations Breast J 12 282 283
10. EP Mammounas B Fisher 2001 Preoperative (neoadjuvant) chemotherapy in patients with breast cancer Semin Oncol 28 389 399
11. V Tsikitis M Chung 2004 Scientific basis of neoadjuvant therapy Semin Breast Dis 7 51 57
12. E Warner M Trudeau 2003 Sensitivity of BRCA1-related breast cancer to neoadjuvant chemotherapy Practical implications. Breast J 9 507 508
13. LJ Pierce M Struderman 2000 Effect of radiotherapy after breast conserving treatment in women with breast cancer and germline BRCA1/2 mutations J Clin Oncol 18 3360 3369
14. B Hafty E Harrold 2002 Outcome of conservatively managed early onset breast cancer by BRCA1/2 status Lancet 359 1471 1477
15. IK Komenaka BA Ditkoff 2004 The development of interval breast malignancies in patients with BRCA mutations Cancer 100 2079 2083
16. JA Ascherman MM Hanasono 2006 Implant reconstruction in breast cancer patients treated with radiation therapy Plast Reconstr Surg 117 359 365
17. SA Narod K Offit 2005 Prevention and management of hereditary breast cancer J Clin Oncol 23 1656 1663
18. LC Hartmann DJ Schaid 1999 Effect of bilateral prophylactic mastectomy in women with a familial history of breast cancer N Engl J Med 340 77 84
19. LC Hartmann TA Sellers 2001 Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers J Natl Cancer Inst 93 1633 1637
20. M Schwartz 2005 Contralateral prophylactic mastectomy: efficacy, satisfaction, regret J Clin Oncol 23 7777 7779
21. TR Rebbeck T Friebel 2004 Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers. The PROSE Study Group J Clin Oncol 221 1055 1062
22. H Meijers-Heijboer B van Geel 2001 Breast cancer after prophylactic bilateral mastectomy in women with BRCA1 or BRCA2 mutations N Engl J Med 345 159 164
23. T Walsh S Casadei 2006 Spectrum of mutations in BRCA1, BRCA2, chek2, and TP53 in families at high risk of breast cancer JAMA 295 1379 1387
24. A Eisen TR Rebbeck 2000 Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer J Clin Oncol 18 1980 1995
25. TR Rebbeck HT Lynch 2002 Prophylactic oophorectomy in carriers of BRCA1 and BRCA2 mutations N Engl J Med 346 1616 1621
26. P Watson SA Narod 2003 Carrier risk status changes resulting form mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast ovarian cancer J Med Genet 40 591 596